Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains - Wikidata - awgldk - TriplyDB

Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains

Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains

http://www.wikidata.org/entity/Q34740339

about

Immunotherapy for tularemia Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112ΔiglB::fljB.Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity Francisella tularensis LVS surface and membrane proteins as targets of effective post-exposure immunization for tularemia.Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice.Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia.B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.Tularemia vaccine development: paralysis or progress?Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection Antibody-Fc receptor interactions in protection against intracellular pathogens.Progress, challenges, and opportunities in Francisella vaccine development.Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis.Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.A Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.Low doses of IgG from atopic individuals can modulate in vitro IFN-γ production by human intra-thymic TCD4 and TCD8 cells: An IVIg comparative approach.Mice Housed at Elevated Vivarium Temperatures Display Enhanced T-cell Response and Survival to Francisella tularensis.Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.

P2860

Q26864945-F5BDE90B-BBD1-4553-A8BA-79A65529DA6C Q27323387-EECEF2E1-A256-4EFD-849A-599434BAE6D4 Q30275022-35B2B245-05F2-4C36-A744-6C998CD33080 Q30411506-24171A2F-8173-425D-9142-2E1F6F7715C9 Q31027494-7A75521F-D72B-442F-A5D6-D62EAB339354 Q34074366-428C5FFE-6B4B-4D3F-9A15-47329843C2D9 Q34087802-14B0DA2E-20AA-4897-BE74-EB07C4FCA601 Q34200786-6EC01044-CF7F-4504-AB28-30924F8FA686 Q34237666-90B3D130-54F1-4F09-977B-B109B77F20A3 Q35072870-0E1CE509-AFC9-496E-8237-D446C12359B3 Q35563406-D21E51DF-F5AF-4E01-AA64-79A3C3DD758E Q35606536-87CD2B6B-064A-42E5-B6A2-9FE2B3480BC5 Q35670540-CC109AAC-B22C-48C1-A849-617A925D1EE9 Q36623123-C4600645-ACD8-431D-A7BE-481F2828C51D Q36675682-85FA3A35-8DCE-4487-BB78-66F072F4A51D Q36908692-4314AD73-BA8D-4183-A7BC-C1025DA0BD02 Q37123754-FBF36A73-64A8-4F6E-B6E1-549F4F49DC0C Q37853942-60E5D459-30B0-49A3-94F6-E70112943845 Q39892106-676E0743-F88F-497A-9022-DA1C2B75675A Q40093204-EEE69503-87E4-4203-84DD-405DD068FF05 Q41989215-D4BB20E7-D7D4-4CD4-B843-31B80655C226 Q47368891-0FD31CAC-3BC2-4A19-B400-A4F0C51BA17C Q47663406-604EA3DC-C3F2-40FE-A10A-3802AFE6634E Q48234349-E59A45A2-12A8-42A4-AE73-E1CC4A4DDBCA Q50046850-D1B9009D-DFF6-4D3D-A5AF-D965D6EDD374 Q52571082-DB6D238D-24BA-4E84-960C-3F82EFFEB778 Q55001017-A77D64AE-1908-4D25-A9A0-C9B95C093462 Q55004992-9EC4167F-C98E-4C9A-A585-4A27F27CCD9D

P2860

Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains

http://www.wikidata.org/entity/Q34740339

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antibodies contribute to effec ...... Francisella tularensis strains

@ast

Antibodies contribute to effec ...... Francisella tularensis strains

@en

Antibodies contribute to effec ...... Francisella tularensis strains

@nl

type

label

Antibodies contribute to effec ...... Francisella tularensis strains

@ast

Antibodies contribute to effec ...... Francisella tularensis strains

@en

Antibodies contribute to effec ...... Francisella tularensis strains

@nl

prefLabel

Antibodies contribute to effec ...... Francisella tularensis strains

@ast

Antibodies contribute to effec ...... Francisella tularensis strains

@en

Antibodies contribute to effec ...... Francisella tularensis strains

@nl

P1433

Q34740339-6E532C80-F539-481C-B5AD-E35E84184B08

P1476

Q34740339-6DC931F6-5D4E-445D-A05A-4133CB724362

P2093

Q34740339-07F0BAA1-73DE-4E9C-8DA6-A3EB228C36BD

Q34740339-0ACDF5B0-B72C-40FF-8D06-3128A3CD8149

Q34740339-4600901A-423B-42B9-9795-09E715D57C86

Q34740339-8B6A665D-E058-43E2-AE7C-8C62C493921D

P2860

Q34740339-02D3B71C-357A-4203-8527-61179B76B22A

Q34740339-074C00C8-60F5-4925-B7CA-094C1D424EB6

Q34740339-095ED9F2-D059-4D78-AC02-19658A1BEB2E

Q34740339-151465E1-1213-4AB6-995B-D14CEFE2AFB0

Q34740339-2C781138-A4C3-48FB-99A2-0F51055E4FCD

Q34740339-32FD725B-3C7F-49F4-AF5F-19E5B8E3AF14

Q34740339-3E24D4E3-5053-4F10-88A3-3922A2AEE89E

Q34740339-48FF92A5-18F3-4E31-BDF8-F87133DE0672

Q34740339-4A8FC496-311E-4F1A-B72D-06D66CFA67D5

Q34740339-4BCA65E3-1716-4DDD-8275-9DE545DF9477

P304

Q34740339-ED3D6C51-7E56-4E21-B4A4-957EA7013D23

P31

Q34740339-F690E00F-4584-4D01-83C9-4188BFF8DE8D

P356

Q34740339-3411735A-A285-4155-9206-5C7B9CA245C1

P407

Q34740339-309447E5-3363-4F88-8EA5-3909097017B0

P433

Q34740339-6BE996CA-563E-4C8B-A81D-071094FBF26C

P478

Q34740339-F4F56A67-9443-40A0-BA94-389C0B011923

P577

Q34740339-1E72EB41-4371-4387-BCC4-6886885D16C9

P698

Q34740339-4F7A6C8C-4FCE-4FAD-A70C-39A5A32ADB09

P921

Q34740339-A1788BDA-CAA8-4E00-9098-0CBA6EE2E78A

P932

Q34740339-B4117F7F-6C6A-41B3-8845-89862AF67C5C

P356

P1433

Infection and Immunity

P1476

Antibodies contribute to effec ...... Francisella tularensis strains

@en

P2093

C Rick Lyons

http://www.w3.org/2001/XMLSchema#string

Gopi Mara-Koosham

http://www.w3.org/2001/XMLSchema#string

Julie A Hutt

http://www.w3.org/2001/XMLSchema#string

Terry H Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.

Tularemia as a biological weapon: medical and public health management.

Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain

Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.

Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.

Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.

Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.

Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.

Immunity against tularemia: passive protection of mice by transfer of immune tissues.

Live vaccine strain of Francisella tularensis: infection and immunity in mice.

P304

1770-1778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00605-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21282410

http://www.w3.org/2001/XMLSchema#string

P921

P932

3067570

http://www.w3.org/2001/XMLSchema#string